Acumen Pharmaceuticals Profit Margin

Acumen Pharmaceuticals's profit margin stands at 115513.33% as of September 2026. That is above the Healthcare sector average of 19.13%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Acumen Pharmaceuticals sits higher the Healthcare benchmark (19.13%) with a profit margin of 115513.33%. That is roughly 603692.4% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 115513.33% for Acumen Pharmaceuticals means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Acumen Pharmaceuticals's profit margin evolved across reporting periods, while the comparison chart places ABOS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, profit margin is commonly used to spot outliers. Acumen Pharmaceuticals's reading of 115513.33% (sector avg 19.13%) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.